This is a preview of subscription content, log in via an institution to check access.
Reference
Wang S, et al. Efficacy and safety of afatinib in a Chinese population with advanced lung adenocarcinoma with sensitive EGFR mutations. Thoracic Cancer 10: 1461-1468, No. 6, Jun 2019. Available from: URL: http://doi.org/10.1111/1759-7714.13095 - China
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1762, 22 (2019). https://doi.org/10.1007/s40278-019-64761-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-64761-x